Bristol-Myers Squibb to Take Part in the UBS Global Healthcare Conference
NEW YORK--(BUSINESS WIRE)--May 14, 2019--
Bristol-Myers Squibb Company (NYSE: BMY) will take part in a fireside chat at the UBS Global Healthcare Conference on Tuesday, May 21, 2019, in New York. Giovanni Caforio, M.D., chairman and chief executive officer will answer questions at 2:30 p.m. ET.
Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190514005094/en/
CONTACT: Media: Carrie Fernandez, 609-252-5222,firstname.lastname@example.org
Investors: Tim Power, 609-252-7509,email@example.com
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL OTHER HEALTH GENERAL HEALTH
SOURCE: Bristol-Myers Squibb Company
Copyright Business Wire 2019.
PUB: 05/14/2019 06:59 AM/DISC: 05/14/2019 06:59 AM